Pfizer applies for booster approval in SA

Pfizer Inc and BioNTech SE have applied to have their coronavirus vaccine approved by the South African Health Regulatory Products Authority for use as a booster.

The vaccine, the most widely used in South Africa for initial inoculation against Covid-19, would be the first to be approved for use as a booster in the mass rollout of vaccines to South Africa.

The authority will assess the data to determine “the safety and efficacy” of its use as a third dose, it said in a statement on Monday.

© 2021 Bloomberg

Join heated discussions with the Moneyweb community, and get full access to our market indicators and data tools while supporting quality journalism.

R63/month or R630/year


You can cancel at any time.